Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments?

BACKGROUND: Unlike cytotoxic agents, novel antineoplastic drugs can variably affect thyroid function and so impair patient outcomes. However, the widely used standard thyroid tests have demonstrated low sensitivity for detecting early thyroid damage that leads to dysfunction of the gland. To find a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Mondello, P., Mian, M., Pitini, V., Cuzzocrea, S., Sindoni, A., Galletti, M., Mandolfino, M., Santoro, D., Mondello, S., Aloisi, C., Altavilla, G., Benvenga, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4900836/
https://ncbi.nlm.nih.gov/pubmed/27330353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados